Patent Opposition Database

Hide annotations

No Annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): P050102058
Who filed: CILFA
Country: Argentina
Opposition type: Pre-Grant
Date: 01-03-2011
Patent type: Polymorphs

Add an annotation

Where in the document

Click within the document, or manually enter the page number below

10 similar patent oppositions

Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)

Countries: India Date: 2011
Matrix Laboratories Ltd. opposition, lopinavir (LPV) , (894/MUMNP/2007 (Divisional of IN/PCT/2002/1243/MUM))

Countries: India Date: 2011
GTPI opposition, lopinavir/ritonavir (LPV/r) , (PI0413882‐1)

Countries: Brazil Date: 2011
Cipla Ltd. opposition, atazanavir (ATV) , (2933/DELNP/2009 (Divisional of 6425/DELNP/2006))

Countries: India Date: 2011
Indian Pharmaceutical Alliance (IPA) opposition, Darunavir and Etravirine, (35/MUMNP/2010)

Countries: India Date: 2011
Indian Network of People Living with HIV/AIDS (INP+) opposition, Raltegravir, (4187/DELNP/2007)

Countries: India Date: 2011
CILFA opposition, efavirenz (EFV) , (P990101586)

Countries: Argentina Date: 2004
CILFA opposition, efavirenz (EFV) , (P990102809)

Countries: Argentina Date: 2004
CILFA opposition, raltegravir (RAL) , (P050104911)

Countries: Argentina Date: 2009
CILFA opposition, tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) , (P060102468)

Countries: Argentina Date: 2009